Business Standard

Monday, January 27, 2025 | 09:50 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Scientists question validity of major hydroxychloroquine study

A spokeswoman for Mandeep R Mehra, the Harvard professor who was the paper's lead author, said on Friday that the study's authors had asked for an independent academic review and audit of their work.

Hydroxychloroquine, coronavirus, covid-19, drug, drugs, pharma, pharmaceutical
Premium

Use of the malaria drugs chloroquine and hydroxychloroquine to prevent and treat Covid-19 has been a focus of intense public attention.

Roni Caryn Rabin | NYT
More than 100 scientists and clinicians have questioned the authenticity of a massive hospital database that was the basis for an influential study published last week that concluded that treating people who have Covid-19 with chloroquine and hydroxy-chloroquine did not help and might have increased the risk of abnormal heart rhythms and death.

In an open letter to The Lancet’s editor, Richard Horton, and the paper’s authors, the scientists asked the journal to provide details about the provenance of the data and called for the study to be independently validated by the World Health Organization or another institution.

A spokeswoman for  Mandeep

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in